CN117327759A - Zanthoxylum seed protein polypeptide and application thereof as feed additive - Google Patents
Zanthoxylum seed protein polypeptide and application thereof as feed additive Download PDFInfo
- Publication number
- CN117327759A CN117327759A CN202311305305.9A CN202311305305A CN117327759A CN 117327759 A CN117327759 A CN 117327759A CN 202311305305 A CN202311305305 A CN 202311305305A CN 117327759 A CN117327759 A CN 117327759A
- Authority
- CN
- China
- Prior art keywords
- seed protein
- protein polypeptide
- enzymolysis
- pepper seed
- pricklyash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 74
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 74
- 241000949456 Zanthoxylum Species 0.000 title claims abstract description 39
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 32
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 28
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 28
- 239000003674 animal food additive Substances 0.000 title claims abstract description 11
- 239000004365 Protease Substances 0.000 claims abstract description 35
- 235000007650 Aralia spinosa Nutrition 0.000 claims abstract description 32
- 108090000526 Papain Proteins 0.000 claims abstract description 31
- 235000019834 papain Nutrition 0.000 claims abstract description 31
- 229940055729 papain Drugs 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 6
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 6
- 229940111202 pepsin Drugs 0.000 claims abstract description 6
- 229920005654 Sephadex Polymers 0.000 claims abstract description 5
- 239000012507 Sephadex™ Substances 0.000 claims abstract description 5
- 239000008367 deionised water Substances 0.000 claims abstract description 4
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 4
- 239000003480 eluent Substances 0.000 claims abstract description 3
- 238000010828 elution Methods 0.000 claims abstract description 3
- 235000002566 Capsicum Nutrition 0.000 claims description 28
- 239000006002 Pepper Substances 0.000 claims description 28
- 241000722363 Piper Species 0.000 claims description 28
- 235000016761 Piper aduncum Nutrition 0.000 claims description 28
- 235000017804 Piper guineense Nutrition 0.000 claims description 28
- 235000008184 Piper nigrum Nutrition 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000009210 therapy by ultrasound Methods 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 12
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 53
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 206010018910 Haemolysis Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000008588 hemolysis Effects 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 239000008103 glucose Substances 0.000 description 13
- 241000607142 Salmonella Species 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 8
- 108010082126 Alanine transaminase Proteins 0.000 description 8
- 102000006395 Globulins Human genes 0.000 description 8
- 108010044091 Globulins Proteins 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 244000089698 Zanthoxylum simulans Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000002949 hemolytic effect Effects 0.000 description 4
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 3
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000252210 Cyprinidae Species 0.000 description 1
- 206010014486 Elevated triglycerides Diseases 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Animal Husbandry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention provides a pricklyash seed protein polypeptide with an antibacterial effect, which is prepared by performing enzymolysis on pricklyash seed protein by pepsin and then performing enzymolysis by papain. And the enzymolysis product of papain is separated and purified by a Sephadex G-25 gel column, deionized water is used as eluent, the elution speed is 0.5ml/min, and the components separated for 20-30min are collected. The pricklyash seed protein polypeptide provided by the invention can be used for preparing an anti-salmonella product. The pricklyash seed protein provided by the invention has an antibacterial effect, and can improve the immunity of organisms, improve the growth performance, reduce the cost and increase the economic benefit when used as a feed additive.
Description
Technical Field
The invention belongs to the technical field of feed additives, and particularly relates to a pricklyash seed protein polypeptide and application thereof as a feed additive.
Background
The pricklyash peel is pericarp of pricklyash peel of Rutaceae plant of Rutaceae, is one of main flavoring in each vegetable system of China, and can also be used as Chinese medicine. The Chinese is the first large-scale production country of the Chinese prickly ash, the current cultivation area reaches 100 ten thousand hectares, the annual output is about 50 ten thousand tons, the Chinese prickly ash seeds are main economic byproducts of the Chinese prickly ash, the output is higher than the Chinese prickly ash peel, however, the Chinese prickly ash seeds are not fully and effectively utilized for a long time, and most of the Chinese prickly ash seeds are burnt or scattered into the field to serve as crop fertilizers and are also often discarded as waste at will.
More researches have shown that the pricklyash seeds are rich in a large amount of grease, protein and amino acid, and have the potential of being used as a good animal feed raw material. The data result shows that the pepper seeds are added into the commercial laying hen diet, so that the laying rate of the laying hen can be improved; proper amount of pricklyash seeds are added into the feed, so that the growth performance of meat chickens and carps can be improved. However, in piglet cultivation, the direct addition of pepper seeds to piglet feed can cause obvious stress reaction of piglets, so that the cultivation effect is not good.
In the prior art, a pricklyash seed protein antibacterial peptide is reported, and is prepared by taking pricklyash seed protein prepared by alkali treatment as a raw material and then carrying out enzymolysis by pepsin. However, the pepper seed protein antibacterial peptide has resistance to escherichia coli only, and has poor antibacterial effect on salmonella which is another main pathogen causing diarrhea of piglets. In addition, the antibacterial peptide prepared by the method contains more antagonistic factors, so that stronger stress reaction can occur to piglets, and the growth of the piglets is influenced.
Disclosure of Invention
The invention provides a pricklyash seed protein polypeptide with an antibacterial effect and application thereof as a feed additive, and the protein peptide can be used for improving the body immunity of cultured animals.
The invention firstly provides a pricklyash seed protein polypeptide, and the preparation method thereof is as follows:
1) Dissolving semen Zanthoxyli protein in ethanol solution, treating at 30-35deg.C to obtain ethanol treatment solution,
wherein the adding concentration of the pricklyash seed protein in the ethanol solution is 50-100mg/ml;
2) Adjusting the pH value of the treatment solution to 2-3 by using hydrochloric acid solution, then adding pepsin for enzymolysis, inactivating enzyme after 2-3 hours of enzymolysis, and cooling to obtain enzymolysis solution;
3) And (3) carrying out ultrasonic treatment on the cooled enzymolysis liquid, wherein the ultrasonic power is 150W, the ultrasonic treatment time is 5min, centrifuging for 10min at 8000r/min after ultrasonic treatment, and taking supernatant, and carrying out vacuum freeze drying to obtain the pricklyash seed protein peptide.
Further, the pricklyash seed protein peptide prepared in the step 3) is subjected to enzymolysis by papain to obtain an enzymolysis product;
wherein papain is subjected to enzymolysis at pH of 5.5-6.8 and enzymolysis temperature of 35 ℃ for 5h.
Furthermore, the pricklyash seed protein polypeptide is prepared by separating and purifying an enzymolysis product obtained by enzymolysis of papain by using a Sephadex G-25 gel column, selecting deionized water as eluent with the elution speed of 0.5ml/min, and collecting components separated for 20-30 min.
The pricklyash seed protein polypeptide provided by the invention can be used for preparing an anti-salmonella product.
The invention also provides another application of the pricklyash seed protein polypeptide, which is an application as a feed additive.
The invention also provides a piglet feed, wherein the pricklyash seed protein polypeptide is added in the feed.
The pricklyash seed protein provided by the invention has an antibacterial effect, and can improve the immunity of organisms, improve the growth performance, reduce the cost and increase the economic benefit when used as a feed additive.
Drawings
Fig. 1: a graph of the concentration and hemolytic activity of the pepper seed protein antibacterial peptide p-C1;
fig. 2: a graph of concentration of enzymatic hydrolysate of papain versus haemolytic activity;
fig. 3: sephadex G-25 gel column separation and purification diagram of enzymolysis product of papain;
fig. 4: the result diagram of the salmonella resistance of the polypeptide, wherein A is the pepper seed protein antibacterial peptide p-C1, B is the enzymolysis product of papain, C is the antibacterial circle of the salmonella resistance of the F5 component of the enzymolysis product of papain,
fig. 5: a graph of the detection result of alanine Aminotransferase (ALT) content in piglet serum;
fig. 6: a Total Protein (TP) content detection result diagram in the serum of each group of piglets;
fig. 7: a graph of the detection result of the content of Globulin (GLO) in the serum of each group of piglets;
fig. 8: a graph of the results of the detection of Glucose (GLU) content in the serum of each group of piglets;
fig. 9: a graph of the detection result of Triglyceride (TG) content in the serum of each group of piglets;
fig. 10: statistics of incidence of diarrhea in piglets in the test group and the control group.
Detailed Description
The present invention will be described in detail with reference to the following examples and the accompanying drawings.
Example 1: preparation of Zanthoxylum seed protein antibacterial peptide p-C1
The preparation method comprises the steps of preparing pepper seed protein by alkali treatment, dissolving the pepper seed protein in a sufficient amount of ethanol solution, preheating in a water bath, adjusting the temperature to 32 ℃, adjusting the pH value of the solution to 2.0 at the same time, adding pepsin for enzymolysis, maintaining the pH value of the solution in the enzymolysis process to 2.0, after enzymolysis for 3 hours, putting into a water bath at 90 ℃ for enzyme deactivation, cooling, pouring the cooled mixture into a beaker, putting into an ultrasonic cleaner with cooling water circulation, ultrasonically extracting the antibacterial peptide with ultrasonic power of 150W for 5 minutes, centrifuging for 10 minutes at 8000r/min after ultrasonic treatment, taking supernatant, and vacuum freeze-drying to obtain the pepper seed protein antibacterial peptide, which is named as p-C1.
Verifying the Minimum Inhibitory Concentration (MIC) of the prepared pricklyash seed protein antibacterial peptide p-C1 on common pathogenic bacteria in piglets, namely the concentration of the minimum pricklyash seed protein antibacterial peptide p-C1 capable of inhibiting bacterial growth and reproduction; the method comprises the following specific steps:
respectively streaking and inoculating strains of pathogenic bacteria to an LB plate culture medium, and culturing at 37 ℃ for 24 hours; inoculating the single colony into 100ml LB liquid medium, shake culturing at 37deg.C and 150r/min overnight to obtain bacterial liquid, and regulating bacterial concentration in bacterial liquid to 5×10 6 CFU/mL。
Diluting the pepper seed protein antibacterial peptide, sequentially adding 10 μl of each pepper seed protein antibacterial peptide into each well of a 96-well plate, and adding 90 μl of fermentation culture solution of each strain with adjusted concentration to a total volume of 100 μl of each well; the final concentration of Zanthoxylum seed protein antibacterial peptide p-C1 in each well was made 200. Mu.g/mL, 180. Mu.g/mL, 150. Mu.g/mL, 130. Mu.g/mL, 100. Mu.g/mL, 80. Mu.g/mL, 60. Mu.g/mL, 50. Mu.g/mL, 25. Mu.g/mL, 12.5. Mu.g/mL, 6.25. Mu.g/mL, 3.12. Mu.g/mL, 1.56. Mu.g/mL, 0.78. Mu.g/mL, 0.39. Mu.g/mL and 0.195. Mu.g/mL, respectively, and after shaking culture at 37℃for 24 hours, the experimental results were measured and recorded with an enzyme-labeled instrument at 600 nm. Simultaneously using coliform bacteria liquid (5 x 10) 6 CFU/mL) and blank LB liquid medium served as negative and positive controls, respectively, representing bacteriostasis rates of 0 and 100%, respectively (table 1).
Table 1: minimum inhibitory concentration table of pepper seed protein antibacterial peptide p-C1 on various bacteria
As can be seen from the results in Table 1, the Zanthoxylum seed protein antibacterial peptide p-C1 has better antibacterial effect only on escherichia coli and bacillus, but has poor antibacterial effect on salmonella, streptococcus suis and haemophilus parasuis which are common in piglets.
Considering that the haemolytic activity on red blood cells is a common index for measuring the toxicity of red blood cells on eukaryotic cells, the cytotoxicity of the prepared pricklyash seed protein antibacterial peptide p-C1 is verified by the following specific method:
50. Mu.l of porcine erythrocytes dissolved in PBS solution at a concentration of 10% are added to a 96-well plate, and 50. Mu.l of Zanthoxylum seed protein antibacterial peptide p-C1 serial diluted with PBS solution are added to make the concentration of the antibacterial peptide in each well 100. Mu.g/mL, 80. Mu.g/mL, 60. Mu.g/mL, 50. Mu.g/mL, 25. Mu.g/mL, 12.5. Mu.g/mL, 6.25. Mu.g/mL, 3.12. Mu.g/mL, 1.56. Mu.g/mL, 0.78. Mu.g/mL, 0.39. Mu.g/mL and 0.195. Mu.g/m, respectively. While 100. Mu.l of 0.2% Triton X-100 was used as positive control (100% hemolysis), negative control wells were added with 100. Mu.l of PBS (0% hemolysis).
After incubation at 37℃for 1 hour, after centrifugation of the cultured 96-well plate at 3000rpm for 5 minutes, 50. Mu.l of the supernatant was aspirated from each experimental well, OD values were measured at 550nm, and the percent hemolysis was calculated from the OD values, which was calculated as follows
Percent% hemolysis = [ (antimicrobial peptide solution experimental well OD value-negative well OD value)/(positive well OD value-negative well OD value) ]x100.
Table 2: percent hemolysis table of different concentrations of pepper seed protein antibacterial peptide p-C1 on pig red blood cells
The results in Table 2 show that p-C1 antimicrobial peptides showed hemolysis to porcine erythrocytes at a concentration of 6. Mu.g/mL and 100% hemolysis at 80. Mu.g/mL (FIG. 1), which is probably the reason why the process for preparing pricklyash seed protein antimicrobial peptides had a high stress response.
Example 2: preparation of Zanthoxylum seed protein peptide with better antibacterial effect on salmonella
Based on the preparation of the pepper seed protein antibacterial peptide p-C1, protease is selected again for enzymolysis of the pepper seed protein antibacterial peptide p-C1, and the Minimum Inhibitory Concentration (MIC) of salmonella is used as a screening standard to screen polypeptides with resistance to escherichia coli and salmonella at the same time.
The specific preparation and screening methods are as follows:
1) Dissolving semen Zanthoxyli protein in ethanol solution, and liquefying at 30-35deg.C to obtain ethanol treatment solution, wherein the concentration of semen Zanthoxyli protein in ethanol solution is 50-100mg/ml;
2) Adjusting the pH value of the treatment solution to 2-3 by using hydrochloric acid solution, then adding pepsin for enzymolysis, inactivating enzyme after 2-3 hours of enzymolysis, and cooling to obtain enzymolysis solution;
3) And (3) carrying out ultrasonic treatment on the cooled enzymolysis liquid, wherein the ultrasonic power is 150W, the ultrasonic treatment time is 5min, centrifuging for 10min at 8000r/min after ultrasonic treatment, taking supernatant, and carrying out vacuum freeze drying to obtain the pricklyash seed protein antibacterial peptide p-C1.
Adding water solution into the prepared pricklyash seed protein antibacterial peptide p-C1 to prepare 50mg/ml solution, and performing enzymolysis with trypsin, papain, subtilisin, neutral protease, bromelain and ficin at 35deg.C for 5 hr. And (3) after enzyme deactivation of the enzymolysis liquid, centrifuging at 3500rpm for 15 minutes, taking supernatant, and performing vacuum freeze drying to obtain enzymolysis products of different enzymes.
Wherein trypsin is subjected to enzymolysis at pH range of 7.9-8.5, and papain is subjected to enzymolysis at pH range of 5.5-6.8.
The enzymatic products of the different enzymes were dissolved in water to prepare mother solutions, and the mother solutions were diluted to 200. Mu.g/mL, 100. Mu.g/mL, 80. Mu.g/mL, 60. Mu.g/mL, 50. Mu.g/mL, 25. Mu.g/mL, 12.5. Mu.g/mL, and 6.25. Mu.g/mL, respectively, for Minimum Inhibitory Concentration (MIC) detection (Table 3).
Table 3: minimum Inhibitory Concentration (MIC) of different enzymatic products against Salmonella (μg/mL)
From the results in Table 3, it can be seen that the enzymatic hydrolysis product of papain has the best bacteriostasis to Salmonella.
The enzymatic hydrolysis product of papain was tested for hemolysis of swine erythrocytes by the method described in example 1. The experimental results are shown in table 4.
Table 4: table of percent hemolysis of enzymatic products of papain at different concentrations on porcine erythrocytes
The results in Table 4 show that the enzymatic product of papain exhibits hemolysis on porcine erythrocytes at a concentration of 12.5. Mu.g/mL, whereas the hemolysis at 100. Mu.g/mL is 68% (FIG. 2). Although the haemolysis is obviously reduced compared with the pepper seed protein antibacterial peptide p-C1, certain haemolysis exists.
Example 3: further purification of enzymatic products of papain
On the basis of retaining the anti-salmonella activity, the enzymolysis product of the papain is further purified, so that hemolytic substances are reduced, and components which cause stress reaction of piglets are reduced.
Preparing enzymolysis product of papain into 50mg/ml solution, separating and purifying with Sephadex G-25 gel column, eluting with deionized water at an eluting speed of 0.5ml/min, and collecting eluting peak at 220 nm. A total of five separation peaks F1-F5 were separated (FIG. 3).
The results of the anti-salmonella activity and hemolysis experiments performed on the products of the five separation peaks according to the detection method of example 2 show that the F5 component separated at 20-30min has not yet been hemolyzed at a concentration of 200 μg/mL on the basis of retaining the anti-salmonella activity. Thus, the F5 component was selected for further investigation.
1. Antibacterial property
Streaking salmonella to be inoculated to a flat-plate culture medium, and culturing at 37 ℃ for 24 hours; the single colonies were picked and inoculated into 100mL of liquid medium, respectively, and shake-cultured overnight at 37℃and 200r/min to prepare a bacterial solution.
Then inoculating 0.1mL of bacterial liquid into different plate culture mediums respectively, and uniformly coating. Round filter paper sheets soaked in 50 mug/mL of pepper seed protein antibacterial peptide p-C1 (figure 4A), enzymolysis product of papain (figure 4B), F5 component (figure 4C) solution of the enzymolysis product of papain are taken out, dried and placed in various plate culture mediums, and the plate culture mediums are placed in a 37 ℃ incubator for 12 hours.
The results show that the pepper seed protein antibacterial peptide p-C1 does not have obvious antibacterial ring, but under the same concentration condition, the antibacterial ring of the F5 component of the enzymolysis product of the papain is obviously larger than that of the enzymolysis product of the papain (figure 4), which shows that the content of the salmonella-resistant component in the F5 component of the enzymolysis product of the papain is higher.
2. Influence on piglet serum index
The antibacterial peptide p-C1 (p-C1) of the pricklyash seed protein, the enzymolysis product (pa-p) of the papain and the F5 component (pa-p-F5) of the enzymolysis product of the papain are prepared into oral liquid with the concentration of 100 mug/mL respectively. Randomly dividing 40 piglets of 14 days old before weaning into 4 groups, namely a Control Group (CG) which is only an aqueous solution, a pepper seed protein antibacterial peptide p-C1 group (p-C1), an enzymolysis product group (pa-p) of papain and an F5 group (pa-p-F5) of an enzymolysis product of papain; each group had 10 piglets. Experiments are respectively drenched with homemade oral liquid/water solution, 2 mL/head/time and 1 time a day except normal feeding. The medicine is continuously infused for 5 days.
After the experiment is finished, five indexes of alanine Aminotransferase (ALT), total Protein (TP), globulin (GLO), glucose (GLU) and Triglyceride (TG) in the collected serum of the experimental piglet are detected by using a kit.
As can be seen from fig. 5, the alanine Aminotransferase (ALT) content in the serum of piglets with different interventions was not significantly different from that of the normal control group (P > 0.05). Alanine Aminotransferase (ALT) is one of the important indexes reflecting whether liver metabolism is normal or whether liver is damaged, and from the analysis result of the index, the intervention of F5 group (pa-p-F5) of enzymatic hydrolysis product of melon protease does not cause liver damage.
As can be seen from FIG. 6, compared with the normal Control Group (CG), the Total Protein (TP) content in the piglet serum of the pa-P-F5 intervention group is obviously increased (P < 0.05) after intervention, the pa-P group also has obvious effect, and the P-C1 group has no obvious effect. The Total Protein (TP) is mainly synthesized by the liver, and the Total Protein (TP) content in the piglet serum is obviously improved by the intervention of pa-p-F5, so that the pa-p-F5 is likely to improve the feed intake and the digestion and absorption capacity of the piglet, so that the liver synthesized protein is increased, and the immunity of the piglet is also improved to a certain extent.
As can be seen from fig. 7, compared with the normal control group, the serum Globulin (GLO) content of the piglets in the intervention group is significantly increased (P < 0.05) after the intervention is performed in a different manner, and the pa-P-F5 group has the best effect, the pa-P group has the inferior effect, and the P-C1 group has the worst effect, which is only higher than the CG group. And the GLO content reflects the organism immunity condition of the piglets, and the GLO is reduced, which means that the organism disease resistance is reduced. From the detection results, the interference of the pa-p-F5 and the pa-p groups leads the GLO content in the piglet serum to be obviously increased, which proves that the pa-p-F5 and the pa-p truly improve the disease resistance of the piglet before weaning.
As can be seen from fig. 8, the Glucose (GLU) content in the piglet sera of the pa-P-F5 and pa-P intervention groups was significantly increased (P < 0.05) after the different manner of dry prognosis compared to the normal control group, and the Glucose (GLU) content in the piglet sera of the P-C1 and CG groups was not significantly changed (P > 0.05) with the highest pa-P-F5 content. The blood glucose concentration in serum is relatively constant and the blood glucose is directly oxidized to supply the energy required for metabolic activity in the animal body. The blood glucose level reflects the amount of glucose absorbed into the blood by the piglet's gut and is directly related to the digestibility of the piglet diet carbohydrates. The test results show that the high-dose intervention group and the high-dose group of the creep feed can increase the glucose content in the blood of the piglets compared with the normal control group. According to analysis, the increase of the blood sugar concentration means that the digestion and absorption effects of the intestinal tracts of the piglets on carbohydrates are obviously enhanced, and the fact that pa-p-F5 and pa-p are used as feed additives can improve the digestion rate of the piglets on nutrients including starch and non-starch polysaccharide.
As can be seen from fig. 9, the Triglyceride (TG) content in the serum of the piglets in the pa-P-F5 and pa-P intervention groups was significantly reduced (P < 0.05) after the dry prognosis in a different manner compared with the normal control group, and the pa-P-F5 intervention group was most reduced and the P-C1 group was not significantly reduced. Triglycerides (TG) are derived from the breakdown of fat, low levels of TG in serum are beneficial to piglet health, and elevated Triglycerides (TG) can induce morbidity in the body.
From the aspect of blood biochemical indexes, the oral liquid of pa-p-F5 and pa-p is safe and effective, the immunity of the piglets before weaning is improved, the purpose of preventing and treating diarrhea is achieved, and the action effect of pa-p-F5 is obviously higher than that of pa-p, which accords with the test result that the piglets in the pa-p-F5 and pa-p intervention group do not have diarrhea. The biochemical indexes of pa-p-F5 and pa-p provided by the invention meet the requirements of declaration of functional feeds and feed additives.
Example 4: effect of pa-p-F on diarrhea in piglets
Preparing F5 component of enzymolysis product of papain into creep feed, randomly dividing 40 piglets into 2 groups, normal Control Group (CG) and F5 component (pa-p-F5) of enzymolysis product of papain, each group comprising 20 piglets, wherein the following steps are:
(1) Normal control group: for 14-day-old piglets before 20 weaning, a pig farm health care program is applied.
(2) Creep feed (pa-p-F5) group: for 14-day-old piglets before 20 weaning, pa-p-F5 is added into feed according to the proportion of 1% and 0.5% for feeding respectively, and the feeding is carried out 1 time a day. Feeding continuously for 5 days.
The piglets were observed daily for diarrhea and the incidence was counted. After the end of the trial (about 6 hours after the last administration), it was observed that the creep feed (pa-p-F5) intervention group did not show diarrhea phenomena in piglets. The proportion of diarrhea of the normal control group occurring in piglets is 30% (figure 10), and according to the statistical result, the oral liquid and the creep feed have better intervention effect on preventing and treating the diarrhea of the piglets before weaning. The polypeptide prepared by the invention has good effect in preventing and treating piglet diarrhea.
Claims (10)
1. The pepper seed protein polypeptide is characterized in that the preparation method of the pepper seed protein polypeptide comprises the following steps:
1) Dissolving pricklyash seed protein in ethanol solution to obtain ethanol treatment solution,
2) Adjusting the pH value of the treatment solution to 2-3 by using hydrochloric acid solution, then adding pepsin for enzymolysis, inactivating enzyme after enzymolysis, and cooling to obtain enzymolysis solution;
3) And carrying out ultrasonic treatment on the cooled enzymolysis liquid, centrifuging after ultrasonic treatment, taking supernatant, and carrying out vacuum freeze drying to obtain the protein polypeptide.
2. The pepper seed protein polypeptide as claimed in claim 1, characterized in that the pepper seed protein is added in ethanol solution at a concentration of 50-100mg/ml.
3. The pepper seed protein polypeptide as claimed in claim 1, wherein the ultrasonic power in 3) is 150W for 5min.
4. The pepper seed protein polypeptide as claimed in claim 1, wherein said centrifugation in 3) is a centrifugation at 8000r/min for 10min.
5. The pepper seed protein polypeptide as claimed in claim 1, wherein said pepper seed protein polypeptide is prepared by subjecting the protein polypeptide obtained in 3) to enzymolysis with papain.
6. The pepper seed protein polypeptide of claim 5, characterized in that the enzymolysis with papain is performed at 5.5-6.8 at 35 ℃ for 5h.
7. The pepper seed protein polypeptide of claim 5, wherein the enzymatic hydrolysate is separated and purified by using a Sephadex G-25 gel column, the eluent is deionized water at an elution rate of 0.5ml/min, and the separated components are collected for 20-30 min.
8. Use of a pricklyash seed protein polypeptide according to any one of claims 1-7 for the preparation of an anti-salmonella preparation.
9. Use of the pricklyash seed protein polypeptide according to any one of claims 1-7 as a feed additive.
10. A piglet feed, characterized in that the piglet feed is added with the pricklyash seed protein polypeptide according to any one of claims 1-7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311305305.9A CN117327759A (en) | 2023-10-10 | 2023-10-10 | Zanthoxylum seed protein polypeptide and application thereof as feed additive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311305305.9A CN117327759A (en) | 2023-10-10 | 2023-10-10 | Zanthoxylum seed protein polypeptide and application thereof as feed additive |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117327759A true CN117327759A (en) | 2024-01-02 |
Family
ID=89275078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311305305.9A Pending CN117327759A (en) | 2023-10-10 | 2023-10-10 | Zanthoxylum seed protein polypeptide and application thereof as feed additive |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117327759A (en) |
-
2023
- 2023-10-10 CN CN202311305305.9A patent/CN117327759A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6422474B2 (en) | Microbial-based process for high quality concentrated protein | |
Yang et al. | Advances in research on solid-state fermented feed and its utilization: The pioneer of private customization for intestinal microorganisms | |
CN105595008B (en) | Laying period compound feed for improving healthy chick rate of egg-laying hens and preparation method thereof | |
CN104472879A (en) | Tea residue feed additive and preparation method thereof | |
CN1997387A (en) | Methods and compositions for improving growth of meat-type poultry | |
Wang et al. | Growth performance and digestion improvement of juvenile sea cucumber Apostichopus japonicus fed by solid‐state fermentation diet | |
CN103609862A (en) | Method for improving feeding nutritive value of sesame seed meal by combining enzymolysis method with fermentation method | |
CN105995071A (en) | Pig feed for early stage of fattening and preparation method of pig feed | |
CN104738305A (en) | Preparation method and application of buckwheat active peptides | |
WO2021003793A1 (en) | Bacillus haynesii ly-23, bacterial agent, application thereof and product using same | |
KR20180011312A (en) | Method for concentrating protein in grain powder | |
CN105941841A (en) | Preparation method of solid-state and multi-microorganism citric acid acidized fermented feed | |
CN109007295A (en) | A kind of Moringa feed addictive, preparation method and purposes | |
CN105859839B (en) | A kind of biologically active peptide and its preparation method and application promoting piglet growth | |
CN102907568B (en) | Cold-region fermented soybean meal industrialized production method | |
CN114365799A (en) | Growing and fattening pig feed capable of improving growth performance and preparation method thereof | |
CN109170130B (en) | Method for preparing fish meal by solid-state fermentation of aquatic product leftovers | |
CN117327759A (en) | Zanthoxylum seed protein polypeptide and application thereof as feed additive | |
CN115181704B (en) | Bacillus licheniformis Y5-39 and application thereof | |
CN103609870B (en) | Take DDGS as the full fermented feed preparation method of large pig of major protein raw material | |
CN110074273A (en) | A kind of preparation method of ganoderma lucidum slag fermentation material | |
Bondi et al. | The action of the digestive enzymes of the carp | |
CN105918641A (en) | Soybean meal biological fermentation feed and preparation method thereof | |
Ghosh et al. | Effects of thermostable bacterial α-amylase on growth feed utilization in rohu, Labeo Rohita (Hamilton), Fingerlings | |
CN111513183A (en) | Method for treating plant anti-nutritional factors by using insect larvae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |